Company / Gross Profit
Glaukos Corp. Gross Profit History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$282.8M
FY2025
5-year range
$213.9M / $289.5M
FY2021-FY2025
Trend
-2.3%
vs FY2024
Sector context
#70 of 95
Health Care
What the data says
At $283M, Glaukos Corp.'s gross profit ranks #70 of 95 in the Health Care sector. Gross Profit has fluctuated over the past 10 years, ranging from $98M in FY2016 to $289M in FY2024.
Based on SEC 10-K filings.
$283M in FY2025 with a 5-year CAGR of +16.2%.
Improved from $239M to $283M over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +9.8%
- 5-Year CAGR
- +16.2%
- 10-Year CAGR
- -
Sector benchmark
#70 of 95 in Health CareTop 74% of 95This company $282.8M Sector average $1.9B
▼
-84.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +16.2%, indicating consistent growth.
- In FY2025, gross profit decreased 2.3% year-over-year.
- Ranks #70 out of 95 companies in the Health Care sector.
- Peak gross profit was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $282.8M | -2.3% |
| FY2024 | $289.5M | +21.0% |
| FY2023 | $239.1M | +11.8% |
| FY2022 | $213.9M | -5.9% |
| FY2021 | $227.4M | +70.7% |
| FY2020 | $133.2M | -32.8% |
| FY2019 | $198.4M | +27.0% |
| FY2018 | $156.2M | +13.0% |
| FY2017 | $138.2M | +40.7% |
| FY2016 | $98.2M | +67.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026